Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colostrum from MERS-CoV Seropositive Camels for COVID-19
NCT06857318Phase 2Completed
- Sponsor
- Hadassah Medical Organization
- Start
- May 2023
- Primary completion
- Aug 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of colostrum in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Hadassah Medical Organization. Primary endpoints: Viral Load at 24 hours and Infectivity at 24 hours. Started May 2023; status: completed.
02
Drugs
colostrum
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT06857318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06857318.